Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Acmispon strigosus

ABSTRACT: Acmispon strigosus Transcriptome or Gene expression

PROVIDER: PRJNA1013256 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29299106_1.fastq.gz	Fastqsanger.gz
	SRR29299106_2.fastq.gz	Fastqsanger.gz
	SRR29299107_1.fastq.gz	Fastqsanger.gz
	SRR29299107_2.fastq.gz	Fastqsanger.gz
	SRR29299108_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Acmispon strigosus

Project description:Acmispon strigosus overview

| PRJNA985359 | ENA

Acmispon strigosus

Project description:Acmispon strigosus Genomic Resources

| PRJNA777132 | ENA

Acmispon strigosus

Project description:Acmispon strigosus haplotype 1 genome sequencing

| PRJNA985258 | ENA

Acmispon strigosus

Project description:Acmispon strigosus Genome sequencing and assembly

| PRJNA1006772 | ENA

Acmispon strigosus

Project description:Acmispon strigosus haplotype 2 genome sequencing

| PRJNA985257 | ENA

Acmispon spp.

Project description:Acmispon spp. Genomic Resources

| PRJNA766245 | ENA

Project description:Sequencing of bradyrhizobia from nodules of Acmispon strigosus

| PRJNA671608 | ENA

Parvifloron D from Plectranthus strigosus: Cytotoxicity Screening of Plectranthus spp. Extracts.

Project description:The Plectranthus genus is commonly used in traditional medicine due to its potential to treat several illnesses, including bacterial infections and cancer. As such, aiming to screen the antibacterial and cytotoxic activities of extracts, sixteen selected Plectranthus species with medicinal potential were studied. In total, 31 extracts obtained from 16 Plectranthus spp. were tested for their antibacterial and anticancer properties. Well diffusion method was used for preliminary antibacterial screening. The minimum inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values of the five most active acetonic extracts (P. aliciae, P. japonicus, P. madagascariensis var. "Lynne", P. stylesii, and P. strigosus) were determined. After preliminary toxicity evaluation on Artemia salina L., their cytotoxic properties were assessed on three human cancer cell lines (HCT116, MCF-7, and H460). These were also selected for mechanism of resistance studies (on NCI-H460/R and DLD1-TxR cells). An identified compound-parvifloron D-was tested in a pair of sensitive and MDR-Multidrug resistance cancer cells (NCI-H460 and NCI-H460/R) and in normal bronchial fibroblasts MRC-5. The chemical composition of the most active extract was studied through high performance liquid chromatography with a diode array detector (HPLC-DAD/UV) and liquid chromatography-mass spectrometry (LC-MS). Overall, P. strigosus acetonic extract showed the strongest antimicrobial and cytotoxic potential that could be explained by the presence of parvifloron D, a highly cytotoxic diterpene. This study provides valuable information on the use of the Plectranthus genus as a source of bioactive compounds, namely P. strigosus with the potential active ingredient the parvifloron D.

| S-EPMC6843537 | biostudies-literature

Biomarks of Resistance to Cetuximab in Colorectal Cancer

Project description:Interventions: A group:Before using cetuximab;B group:After progression of disease:no Primary outcome(s): KRAS gene sequence;NRAS gene sequence;BRAF gene sequence;PIK3CA gene sequence;EGFR gene sequence;EGFR gene copy numbers;EGFR expression;Her2 expression;c-Met expression;PTEN expression Study Design: historical control

| 2671639 | ecrin-mdr-crc

Project description:Sequencing of bradyrhizobia associated with Acmispon

| PRJNA1002801 | ENA